Disposition kinetics of difloxacin in rabbit after intravenous and intramuscular injection of dicural

Veterinary Research Communications

Volumn 29, Issue 4, 2005, Pages 297-304

  Abd El Aty, A M ^a   Goudah, A ^a   Ismail, M ^a   Shimoda, M ^b  

^a Cairo University   (Egypt)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Agar plate diffusion; Difloxacin; Rabbits

Indexed keywords

AGAR; DICURAL; DIFLOXACIN;

AGAR GEL DIFFUSION; ANIMAL EXPERIMENT; ARTICLE; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; ESCHERICHIA COLI; FEMALE; MALE; NONHUMAN; PLASMA HALF LIFE; PLASMA PROTEIN BINDING; RABBIT; SINGLE DRUG DOSE; STEADY STATE; TISSUE DISTRIBUTION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CIPROFLOXACIN; FEMALE; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; RABBITS; TISSUE DISTRIBUTION;

ORYCTOLAGUS CUNICULUS;

EID: 8844278382     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:VERC.0000048503.05426.68     Document Type: Article

References (22)

1. Atef, M., El-Banna, H.A., Abd El-Aty, A.M. and Goudah, A., 2002. Pharmacokinetics of difloxacin in goats. Deutsche Tierärztliche Wochenschrift, 109, 320-323
2. Boscia, J.A., Kobasa, W.D. and Kaye, D., 1988. Comparison of difloxacin, enoxacin and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy, 32, 262-264
3. British Pharmacopoeia, 1980. Biological assay of antibiotics. In: British Pharmacopoeia, vol. 2, appendix 14, (HMSO/Cambridge University Press, London/Cambridge), 122-124
4. Broome, R.L., Brooks, D.L., Babish, J.G., Copeland, D.D. and Conzelman, G.M., 1991. Pharmacokinetic properties of enrofloxacin in rabbits. American Journal of Veterinary Research, 52, 1835-1841
5. Brown, S.A., 1996. Fluoroquinolone in animal health. Journal of Veterinary Pharmacology and Therapeutics, 19, 1-14
6. Cabanes, A., Arboix, M., Garcia Anton, J.M. and Reig, F., 1992. Pharmacokinetic of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research, 53, 2090-2093
7. Craig, A.W. and Suh, B., 1980. Protein binding and the antibacterial effects: Methods for determination of protein binding. In: V. Lorian (ed.), Antibiotics in Laboratory Medicine, (Williams and Wilkins, Baltimore, MD), 265-297
8. Fernandes, P.B., 1988. Mode of action, and in vitro and in vivo activity of the fluoroquinolones. Journal of Clinical Pharmacology, 28, 156-168
9. Frazier, D.L., Thompson, L., Trettien, A. and Evans, E.I., 2000. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 23, 293-302
10. Galinsky, R.E. and Svensson, C.K., 1995. Basic pharmacokinetics. In: J.P. Remington (ed.), The Science and Practice of Pharmacy, 19th edn, (Mack Publishing Company, Easton, PA), 724-740
11. Gavrielli, R., Yagil, R., Ziv, G., Creveld, C. and Glickman, A., 1995. Effect of water deprivation on the disposition kinetics of enrofloxacin in camels. Journal of Veterinary Pharmacology and Therapeutics, 18, 333-339
12. Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics, 2nd edn, (Marcel Dekker, New York), 409-417
13. Granneman, G.R., Snyder, K.M. and Shu, V.S., 1986. Difloxacin metabolism and pharmacokinetics in human after single oral doses. Antimicrobial Agents and Chemotherapy, 30, 689-693
14. Haddad, N.S., Pedersoli, W.M., Ravis, W.R., Fazeli, M.H. and Carson, R.L. Jr, 1985. Combined pharmacokinetics of gentamicin in pony mares after a single intravenous and intramuscular administration. American Journal of Veterinary Research, 46, 2004-2007
15. Inui, T., Taira, T., Matsushita, T. and Endo, T., 1998. Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken. Xenobiotica, 28, 887-893
16. Marangos, M.N., Zhu, Z., Nicolau, D.P, Klepser, M.E. and Nightingale, C.H., 1997. Disposition of ofloxacin in female New Zealand White rabbits. Journal of Veterinary Pharmacology and Therapeutics, 20, 17-20
17. Peloquin, C.A., Cumbo, T.J., Nix, D.E., Sands, M.F. and Schentag, J.J., 1989. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections: Impact of plasma concentrations, organism MIC, and clinical condition on bacterial eradication. Archive of Internal Medicine, 149, 2269-2273
18. Prescott, J.F. and Baggot, J.D., 1993. Antimicrobial Therapy in Veterinary Medicine, 2nd edn, (Iowa State University Press, Ames, IA , 100-104
19. Spreng, M., Deleforge, J., Thomas, V., Boisrame, B. and Drugeon, H., 1995. Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284-289
20. Stamm, J.M., Hanson, C.W., Chu, D.T., Bailer, R., Vojtko, C. and Fernandes, P.B., 1986. In vitro evaluation of A-56619 (Difloxacin) A-56620: New aryl-fluoroquinolones. Antimicrobial Agents and Chemotherapy, 29, 193-200
21. Wolfson, J.S. and Hooper, D.C., 1985. The fluoroquinolones: Structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy, 28, 581-586
22. Wolfson, J. S. and Hooper, D.C., 1991. Overview of fluoroquinolone safety. American Journal of Medicine, 91, 153S-161S